Sponsor:
M.D. Anderson Cancer Center
Code:
NCT06434363
Conditions
Autoimmune Disorders
Systemic Sclerosis
Systemic Lupus Erythematosus
Lupus
Lupus Nephritis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tafasitamab
Fludarabine phosphate
Cyclophosphamide
Tafasitamab and NK cells
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-17. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2025-07-23.